Cooley advised Cardlytics on its $75.7 million initial public offering of 5,821,355 shares of common stock, including 421,355 shares sold pursuant to the partial exercise of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
